About-cancer/treatment/drugs/defibrotide-sodium/zh

去纤蛋白钠

该页面包含有关去纤蛋白钠的简要信息，以及一些链接，这些链接指向有关该药物的使用，研究结果和正在进行的临床试验的更多信息。

美国品牌名称

Defitelio

FDA 批准

是

该药物的FDA标签信息可从DailyMed获得。

用于癌症

去纤蛋白钠被批准用于治疗：

• 肝静脉闭塞性疾病 成人和儿童（也称为正弦窦阻塞综合征）在接受干细胞移植后也有肾脏或肺部疾病。

更多关于去纤蛋白钠

NCI药物词典中的定义-该药物的详细科学定义和其他名称。

MedlinePlus有关去纤蛋白钠的信息-有关该药物重要信息的俗语摘要，可能包括以下内容：

• 关于这种药物的警告，

• 这种药物的用途和用法，

• 在使用这种药物之前，您应该告诉医生什么，

• what you should know about this drug before using it,

• other drugs that may interact with this drug, and

• possible side effects.

Drugs are often studied to find out if they can help treat or prevent conditions other than the ones they are approved for. This patient information sheet applies only to approved uses of the drug. However, much of the information may also apply to unapproved uses that are being studied.

Clinical Trials Accepting Patients

Find Clinical Trials for Defibrotide Sodium - Check for trials from NCI's list of cancer clinical trials now accepting patients.

Important: The drug information on this page is meant to be educational. It is not a substitute for medical advice. The information may not cover all possible uses, actions, interactions, or side effects of this drug, or precautions to be taken while using it. Please see your health care professional for more information about your specific medical condition and the use of this drug.